Quinaglute Dura-Tabs

• Antimalarials
• Antiarrhythmic Agents
• Antiarrhythmic Agents
• ATC:C01BA01

• Apo-Quinidine
• Biquin Durules
• Cardioquin
• Chinidin
• Cin-Quin
• Coccinine
• Conchinin
• Conchinine
• Conquinine
• Duraquin
• Kinidin
• Novoquinidin
• Pitayin
• Pitayine
• Quin-Release
• Quinact
• Quinaglute
• Quinaglute Dura-Tabs
• Quinalan
• Quinate
• Quinatime
• Quindine
• Quinicardine
• Quinidex
• Quinidex Extentabs
• Quinidine Gluconate
• Quinidine Sulfate
• Quinine, Polymers
• Quinora

No information avaliable

C₂₀H₂₄N₂O₂

http://www.rxlist.com/cgi/generic/quinidine.htm

Quinaglute_Dura-Tabs FDA

No hay información disponible

324.417 g/mol

174 ^oC

140 mg / L

Solid

2.534

Solución

Para el tratamiento de pre-excitación ventricular y arritmias cardíacas

Quinidina, un anticonvulsivo fenitoína, se usa solo o junto con fenobarbital u otros anticonvulsivos para gestionar crisis tónico-clónicas, ataques psicomotores, los síndromes de dolor neuropático diabético incluyendo neuropatía, inducidas por digitálicos arritmias cardíacas y arritmias cardíacas asociadas con prolongación del intervalo QT.

No hay información disponible

No hay información disponible

Before prescribing QUINAGLUTE® as prophylaxis against recurrence of atrial fibrillation, the physician should inform the patient of the risks and benefits to be expected. Discussion should include the facts

• that the goal of therapy will be a reduction (probably not to zero) in the frequency of episodes of atrial fibrillation; and
• that reduced frequency of fibrillatory episodes may be expected, if achieved, to bring symptomatic benefit; but
• that no data are available to show that reduced frequency of fibrillatory episodes will reduce the risks of irreversible harm through stroke or death; and in fact
• that such data as are available suggest that treatment with QUINAGLUTE® is likely to increase the patient's risk of death.

To confirm whether this is the most current prescribing information available on Quinaglute®, or to obtain the most current prescribing information, please call Berlex Laboratories at 1-888-BERLEX-4 (choose option #4, Product Usage Information).

Humanos y otros mamíferos